Last reviewed · How we verify
Zolpidem CR 12.5mg
At a glance
| Generic name | Zolpidem CR 12.5mg |
|---|---|
| Also known as | Stillnox CR 12.5mg |
| Sponsor | Associação Fundo de Incentivo à Pesquisa |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effects of Zolpidem CR® in Sleep and Heart Recovery in Cardiac Intensive Care Unit Patients (PHASE4)
- Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) in Patients With Chronic insomNIA (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Zolpidem CR 12.5mg CI brief — competitive landscape report
- Zolpidem CR 12.5mg updates RSS · CI watch RSS
- Associação Fundo de Incentivo à Pesquisa portfolio CI